Frontiers in Immunology | Cancer Immunity and Immunotherapy

Original Research

Published on 06 Dec 2024

Hypoxia reconstructed colorectal tumor microenvironment weakening anti-tumor immunity: construction of a new prognosis predicting model through transcriptome analysis

in Cancer Immunity and Immunotherapy

Ruizhi Zhang
Yisong Gao
Chong Li
Ruikang Tao
Gan Mao
Tianyu Song
Wenxiang Nie
Suao Liu
Kaixiong Tao
Wei Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1425687

845 views

Review

Published on 06 Dec 2024

Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications

in Cancer Immunity and Immunotherapy

Meshack Bida
Thabiso Victor Miya
Rodney Hull
Zodwa Dlamini

Frontiers in Immunology

doi 10.3389/fimmu.2024.1497522

938 views

Original Research

Published on 06 Dec 2024

Exploring the heterogeneity of osteosarcoma cell characteristics and metabolic states and their association with clinical prognosis

in Cancer Immunity and Immunotherapy

Sen Qin
YaoFeng Hu
RuCui Deng
Zhe Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1507476

776 views

Systematic Review

Published on 06 Dec 2024

Efficacy and safety of adding immune checkpoint inhibitors to first-line standard therapy for recurrent or advanced cervical cancer: a meta-analysis of phase 3 clinical trials

in Cancer Immunity and Immunotherapy

Xinmiao Zhang
Jinhai Shen
Mengfan Huang
Rongxia Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1507977

1,054 views
1 citation

Original Research

Published on 06 Dec 2024

The pan-cancer landscape of aldo-keto reductase1B10 reveals that its expression is diminished in gastric cancer

in Cancer Immunity and Immunotherapy

Anqi Wu
Hao Li
Mengnan Gao
Juan Liang
Jiaqi Huang
Jaume Farrés
Deliang Cao
Guoqing Li

Frontiers in Immunology

doi 10.3389/fimmu.2024.1488042

929 views

Opinion

Published on 06 Dec 2024

Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy

in Cancer Immunity and Immunotherapy

Xiaoyan Qi
Cheng Cheng
Dawei Zhang
Zongjiang Yu
Xiangwei Meng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1488345

650 views

Original Research

Published on 06 Dec 2024

NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy

in Cancer Immunity and Immunotherapy

Serena Cecchetti
Cristina Federici
Rossella Canese
Egidio Iorio
Veronica Huber
Maria Elena Pisanu
Mattea Chirico
Elisabetta Iessi
Serena Camerini
Marialuisa Casella

Frontiers in Immunology

doi 10.3389/fimmu.2024.1503857

1,130 views
1 citation

Systematic Review

Published on 06 Dec 2024

Association between glucose to lymphocyte ratio and prognosis in patients with solid tumors

in Cancer Immunity and Immunotherapy

Rongqiang Liu
Yankun Shen
Jiahui Cui
Wangbin Ma
Jianguo Wang
Chen Chen
Weixing Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1454393

871 views

Systematic Review

Published on 06 Dec 2024

Comparison of the efficacy and safety of perioperative immunochemotherapeutic strategies for locally advanced esophageal cancer: a systematic review and network meta-analysis

in Cancer Immunity and Immunotherapy

Jiao Zhang
Peixi Zhao
Rui Xu
Le Han
Wenjuan Chen
Yili Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478377

1,482 views

Original Research

Published on 06 Dec 2024

Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression

in Cancer Immunity and Immunotherapy

Oanh T. P. Nguyen
Sandra Lara
Giovanni Ferro
Matthias Peipp
Sandra Kleinau

Frontiers in Immunology

doi 10.3389/fimmu.2024.1483617

865 views

Original Research

Published on 06 Dec 2024

Integrative multi-omics analysis reveals a novel subtype of hepatocellular carcinoma with biological and clinical relevance

in Cancer Immunity and Immunotherapy

Shizhou Li
Yan Lin
Xing Gao
Dandan Zeng
Weijie Cen
Yuejiao Su
Jingting Su
Can Zeng
Zhenbo Huang
Haoyu Zeng

Frontiers in Immunology

doi 10.3389/fimmu.2024.1517312

2,809 views

Brief Research Report

Published on 05 Dec 2024

Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinoma

in Cancer Immunity and Immunotherapy

Valerie Glutsch
Patrick Schummer
Matthias Goebeler
Anja Gesierich
Bastian Schilling

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495004

764 views

Original Research

Published on 05 Dec 2024

Tocilizumab in combination with corticosteroids: potential for managing cancer cachexia with systemic hyperinflammation

in Cancer Immunity and Immunotherapy

Ping Chen
Dingyi Wang
Zhouwei Zhan
Ling Chen
Yu Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1477310

845 views

Correction

Published on 05 Dec 2024

Corrigendum: Research progress of CD80 in the development of immunotherapy drugs

in Cancer Immunity and Immunotherapy

Lanying Li
Lei Yang
DePeng Jiang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1536312

300 views

Original Research

Published on 05 Dec 2024

Immune-related diagnostic markers for benign prostatic hyperplasia and their potential as drug targets

in Cancer Immunity and Immunotherapy

YaXuan Wang
Jing Wang
Jibin Liu
HaiXia Zhu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1516362

1,345 views
1 citation

Original Research

Published on 05 Dec 2024

Immune-checkpoint HLA-G gene polymorphisms, 3’-UTR types and their association with hepatocellular carcinoma and treatment response in Indian population

in Cancer Immunity and Immunotherapy

Neeti Nadda
Renu Yadav
Neelanjana Roy
Nita Singh
Sonu Kumar
Shashi Bala Paul
Shivanand Gamanagatti
Anoop Saraya
Shalimar
Baibaswata Nayak

Frontiers in Immunology

doi 10.3389/fimmu.2024.1459749

870 views

Navigation group

Articles

Hypoxia reconstructed colorectal tumor microenvironment weakening anti-tumor immunity: construction of a new prognosis predicting model through transcriptome analysis

Tumor-infiltrating lymphocytes in melanoma: from prognostic assessment to therapeutic applications

Exploring the heterogeneity of osteosarcoma cell characteristics and metabolic states and their association with clinical prognosis

Efficacy and safety of adding immune checkpoint inhibitors to first-line standard therapy for recurrent or advanced cervical cancer: a meta-analysis of phase 3 clinical trials

The pan-cancer landscape of aldo-keto reductase1B10 reveals that its expression is diminished in gastric cancer

Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy

NK cells-derived extracellular vesicles potency in the B cell lymphoma biotherapy

Association between glucose to lymphocyte ratio and prognosis in patients with solid tumors

Comparison of the efficacy and safety of perioperative immunochemotherapeutic strategies for locally advanced esophageal cancer: a systematic review and network meta-analysis

Rituximab-IgG2 is a phagocytic enhancer in antibody-based immunotherapy of B-cell lymphoma by altering CD47 expression

Integrative multi-omics analysis reveals a novel subtype of hepatocellular carcinoma with biological and clinical relevance

Re-exposition to ipilimumab plus nivolumab in metastatic Merkel cell carcinoma

Tocilizumab in combination with corticosteroids: potential for managing cancer cachexia with systemic hyperinflammation

Corrigendum: Research progress of CD80 in the development of immunotherapy drugs

Immune-related diagnostic markers for benign prostatic hyperplasia and their potential as drug targets

Immune-checkpoint HLA-G gene polymorphisms, 3’-UTR types and their association with hepatocellular carcinoma and treatment response in Indian population